Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Endostar for Refractory Malignant Pleural Effusions in NSCLC
NCT02005120Phase 2Unknown
- Sponsor
- Zhejiang University
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in malignant pleural effusion (MPE), sponsored by Zhejiang University. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02005120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005120.